Kurekci, G. K. Et Al. 2017. In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes. 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back , (Jerusalem, Israel), 171.

Kurekci, G. K., Unsal, S., & Dincer, P. R., (2017). In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes . 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back (pp.171). Jerusalem, Israel

Kurekci, G., S. Unsal, And PERVİN RUKİYE DİNÇER. "In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes," 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back, Jerusalem, Israel, 2017

Kurekci, G. K. Et Al. "In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes." 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back , Jerusalem, Israel, pp.171, 2017

Kurekci, G. K. Unsal, S. And Dincer, P. R. (2017) . "In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes." 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back , Jerusalem, Israel, p.171.

@conferencepaper{conferencepaper, author={G. Kayman Kurekci Et Al. }, title={In vivo targeted mutagenesis via CRISPR/Cas9 and TALEN in zebrafish enables rapid screening of candidate rare diseases genes}, congress name={42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back}, city={Jerusalem}, country={Israel}, year={2017}, pages={171} }